fazarabine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crowley, JJ; Goodwin, JW; Livingston, RB; Panella, TJ; Williamson, SK | 1 |
1 trial(s) available for fazarabine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Middle Aged | 1995 |